Research Paper Volume 11, Issue 2 pp 536—548
Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease
Figure 1. Overview of the experimental design. APP/PS1 and WT mice were treated with geniposide (50 mg/kg/d) or water, respectively, via intragastric administration every day for 8 weeks. The NOR test was conducted in the sixth week, and the MWM test was conducted in the seventh week. On week eight mice were killed for biochemical analyses.